UnitedHealth Group Inc. CEO Andrew Witty is resigning unexpectedly, citing “personal reasons,” according to a company announcement released on Tuesday.
This decision comes at a turbulent time for healthcare companies, especially in light of the recent tragic incident involving Brian Thompson, the CEO of UnitedHealthcare, a subsidiary of UnitedHealth.
Former CEO and current chairman, Stephen Hemsley, is set to take over the role again. He has been leading the company since 2021 with notable efficiency.
The timing of Witty’s resignation coincides with growing investor concerns. UnitedHealth shares have plummeted by over 35% this year, with a steep decline of 22% occurring just on the first day of April.
“The company has an excellent opportunity for growth, especially as it focuses on healthcare improvements and potential,” Hemsley stated.
“We aim to meet our long-term growth targets of 13-16% in this process.”
During Hemsley’s tenure from 2006 to 2017, UnitedHealth transformed from an insurance provider into a major $400 billion conglomerate, expanding into data services, pharmacy benefits management, and physician groups.
Meanwhile, Witty’s departure reflects ongoing challenges, including scrutiny from the Department of Justice (DOJ) and a cyberattack linked to Thompson’s murder, as noted by Killar Izimangione.
Izimangione, now 27, faces serious charges related to the case and could receive the death penalty, as per DOJ allegations.
UnitedHealth also announced it would retract its revised revenue projections for 2025, attributing the changes to unexpected high healthcare costs associated with new Medicare enrollees.
In an effort to reassure anxious investors during the April revenue call, Witty addressed the need for operational adjustments amidst significant financial losses. However, the market’s reaction was unfavorable, leading to a considerable drop in stock value.
Since that decline, stock values have decreased further by 17%, resulting in nearly $70 billion in lost market value.
“Hemsley offers a unique blend of strategic vision and operational insight,” said Michele Hooper, the lead independent director on the UnitedHealth board.
“We trust his leadership will help guide the company through these challenging times.”
Reports indicate that Witty will transition to a role as a senior advisor during this period.
In addition, UnitedHealth is facing lawsuits from shareholders, alleging that the company concealed the economic repercussions stemming from consumer dissatisfaction following Thompson’s murder.
The lawsuit filed in Manhattan court claims UnitedHealth misled investors regarding its operational direction.
